Roncati Luca, Manenti Antonio
Department of Surgery, Medicine, Dentistry and Morphological Sciences with interest in Transplantation, Oncology and Regenerative Medicine, University of Modena and Reggio Emilia, Modena, Italy.
Brain Hemorrhages. 2022 Nov 8. doi: 10.1016/j.hest.2022.11.001.
It is news of 28 October 2022 that the Pharmacovigilance Risk Assessment Committee of the European Medicines Agency has recommended to add heavy menstrual bleeding among the side effects of unknown frequency inside the package insert of nucleoside-modified messenger ribonucleic acid vaccines to prevent coronavirus disease 2019 (COVID-19). The decision has been made in the light of the numerous reports of unexpected menstrual changes or abnormal uterine bleeding following COVID-19 vaccination. Here we advance a possible involvement of the particular adenohypophyseal microcirculation in these strange and still unexplained events.
2022年10月28日有消息称，欧洲药品管理局药物警戒风险评估委员会建议在预防2019冠状病毒病（COVID-19）的核苷修饰信使核糖核酸疫苗的药品说明书中，将月经过多列为频率不明的副作用之一。该决定是鉴于有大量报告称接种COVID-19疫苗后出现意外月经变化或子宫异常出血。在此，我们提出腺垂体特殊微循环可能与这些奇怪且仍无法解释的事件有关。
